Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin-Reference-Cited by-同舟云学术

Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin

Published:2021-02 Issue:1 Volume:15 Page:132-137
ISSN:1751-9918
Container-title:Primary Care Diabetes
language:en
Short-container-title:Primary Care Diabetes

Author:

Jammah Anwar Ali^ORCID

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine,Family Practice

Reference25 articles.

1. Clinical inertia in patients with T2DM requiring insulin in family practice;Harris;Can. Fam. Physician,2010

2. Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus;Galligan;Intern. Med. J.,2016

3. Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study;Dale;Prim. Care Diabetes,2010

4. Treatment intensification in Type 2 Diabetes: A real-world study of 2-OAD regimens, GLP-1 RAs, or basal insulin;Blonde;Diabetes Ther.,2018

5. Management of hyperglycemia in Type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetes Care,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes;Diabetology International;2024-01-08

2. Efficacy and safety of iGlarLixi versus IDegAsp : Results of a systematic literature review and indirect treatment comparison;Diabetes, Obesity and Metabolism;2021-08-31